{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:43:06Z","timestamp":1793256186530,"version":"4.5.0"},"reference-count":33,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223004"],"award-info":[{"award-number":["223004"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wellcomeopenresearch.org"],"crossmark-restriction":false},"short-container-title":["Wellcome Open Res"],"abstract":"<ns3:p>Background Novel host-directed therapies are urgently needed for patients with dengue, particularly those at high risk of developing severe disease. Broad immunosuppression using corticosteroids in unselected patients with dengue has so far been unsuccessful. Patients with hyperinflammation (raised CRP and\/or ferritin levels) are at highest risk of poor outcomes in dengue. Anakinra is a licensed, bio-engineered form of the naturally occurring IL-1R antagonist which has shown efficacy in other acute viral-associated hyperinflammatory syndromes. Methods This is a randomized placebo-controlled phase II trial of anakinra in 160 patients \u2265 12 years old, diagnosed as having dengue with warning signs or severe dengue and the hyperinflammatory syndrome (plasma ferritin &gt;2000 ng\/ml). Participants will receive a 4-day course of either anakinra or placebo. The primary endpoint is the efficacy of anakinra measured by the delta mSOFA score* (change in mSOFA score over 4 days after randomization). The accompanying immunological and transcriptomic analyses aim to identify novel mechanisms and pathways that may represent future biomarkers and therapeutic targets. Discussion The observed immunomodulatory benefit of anakinra in acute viral-associated hyperinflammatory syndromes including COVID-19 and auto-immune diseases makes this medication a promising potential treatment for dengue patients with hyperinflammation. This trial will assess the safety and efficacy of anakinra in patients with severe dengue or at high risk of developing life-threatening dengue disease. Registration ClinicalTrials.gov (NCT05611710).<\/ns3:p>","DOI":"10.12688\/wellcomeopenres.21017.1","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T13:05:06Z","timestamp":1732280706000},"page":"689","update-policy":"https:\/\/doi.org\/10.12688\/wellcomeopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Anakinra for dengue patients with hyperinflammation: protocol for a randomized double-blind placebo-controlled trial"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1916-2678","authenticated-orcid":false,"given":"Tran Bang","family":"Huyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-6548","authenticated-orcid":false,"given":"Huynh Trung","family":"Trieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-3041","authenticated-orcid":false,"given":"Nguyen Lam","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5960-7849","authenticated-orcid":false,"given":"Nguyen","family":"Minh Nguyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Thi Hoai","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5507-0415","authenticated-orcid":false,"given":"Angela","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi My","family":"Linh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Trong","family":"Thuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thanh","family":"Phong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong Ngoc","family":"Trung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Cam","family":"Huong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thi Dong","family":"Vien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh Thi Le","family":"Duyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8694-5272","authenticated-orcid":false,"given":"Vo Thi My","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-3155","authenticated-orcid":false,"given":"Ronald","family":"Geskus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Vinh","family":"Tho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-0918","authenticated-orcid":false,"given":"Evelyne","family":"Kestelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Tu","family":"Qui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-7819","authenticated-orcid":false,"given":"Sophie","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"504-7","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue.","volume":"496","author":"S Bhatt","year":"2013","journal-title":"Nature."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"1423-32","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue.","volume":"366","author":"C Simmons","year":"2012","journal-title":"N Engl J Med."},{"key":"ref-3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0147-9","article-title":"Predicting outcome from dengue.","volume":"12","author":"S Yacoub","year":"2014","journal-title":"BMC Med."},{"key":"ref-4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003025","article-title":"Dengue therapeutics, chemoprophylaxis, and allied tools: State of the art and future directions.","volume":"8","author":"J Whitehorn","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1216-24","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in  vietnamese patients: a randomized, placebo-controlled trial.","volume":"55","author":"D Tam","year":"2012","journal-title":"Clin Infect Dis."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"e277-e278","DOI":"10.1016\/S2666-5247(21)00087-2","article-title":"Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?","volume":"2","author":"A McBride","year":"2021","journal-title":"Lancet Microbe."},{"key":"ref-7","first-page":"S1-13","article-title":"The IL-1 family and inflammatory diseases.","volume":"20","author":"C Dinarello","year":"2002","journal-title":"Clin Exp Rheumatol."},{"key":"ref-8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003214","article-title":"Hyperferritinaemia in dengue virus infected patients Is associated with immune activation and coagulation disturbances.","volume":"8","author":"C van de Weg","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005973","article-title":"IL-1\u03b2\/IL-6\/CRP and IL-18\/ferritin: distinct inflammatory programs in infections.","volume":"12","author":"J Slaats","year":"2016","journal-title":"PLoS Pathog."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"218-226","DOI":"10.1093\/cei\/uxab024","article-title":"Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA.","volume":"207","author":"C Rich","year":"2022","journal-title":"Clin Exp Immunol."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.3390\/jcm10194462","article-title":"The effect of anakinra in hospitalized patients with COVID-19: an updated systematic review and meta-analysis.","volume":"10","author":"K Kyriakoulis","year":"2021","journal-title":"J Clin Med."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"e253-e261","DOI":"10.1016\/S2665-9913(21)00012-6","article-title":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.","volume":"3","author":"G Cavalli","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref-13","article-title":"Kineret","year":"2022"},{"key":"ref-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinpr.2020.100043","article-title":"Fatal primary dengue-induced Haemophagocytic Lymphohistiocytosis (HLH) in a returning traveller from India treated with anakinra for the first time.","volume":"7\u20138","author":"T Kanitkar","year":"2020","journal-title":"Clin Infect Pract."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"13-9","DOI":"10.1007\/s15010-014-0683-4","article-title":"Ferritin levels predict severe dengue.","volume":"43","author":"R Soundravally","year":"2015","journal-title":"Infection."},{"key":"ref-16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012071","article-title":"Endothelial and inflammatory pathophysiology in dengue shock: new insights from a  prospective cohort study in vietnam.","volume":"18","author":"A McBride","year":"2024","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"345-56","DOI":"10.1111\/j.1365-2249.2006.02996.x","article-title":"NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.","volume":"143","author":"E Azeredo","year":"2006","journal-title":"Clin Exp Immunol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"735-43","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of Hemophagocytic Lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.","volume":"104","author":"M Jordan","year":"2004","journal-title":"Blood."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"1338-47","DOI":"10.1093\/infdis\/jiac093","article-title":"Hyperinflammatory syndrome, natural killer cell function, and genetic polymorphisms in the pathogenesis of severe dengue.","volume":"226","author":"N Vuong","year":"2022","journal-title":"J Infect Dis."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment.","volume":"6","author":"F Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fimmu.2019.00395","article-title":"Pathogenic gene mutations or variants identified by targeted gene sequencing in adults with hemophagocytic lymphohistiocytosis.","volume":"10","author":"Y Miao","year":"2019","journal-title":"Front Immunol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1139-41","DOI":"10.1038\/ng.960","article-title":"Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1.","volume":"43","author":"C Khor","year":"2011","journal-title":"Nat Genet."},{"key":"ref-23","article-title":"Guideline for diagnosis and treatment of dengue disease","year":"2019"},{"key":"ref-24","first-page":"29-29","article-title":"Recommendations for Treatment.","volume":"41","year":"2006","journal-title":"Psychiatr News."},{"key":"ref-25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07705-8","article-title":"A modified Sequential Organ Failure Assessment score for dengue: development, evaluation and proposal for use in clinical trials.","volume":"22","author":"A McBride","year":"2022","journal-title":"BMC Infect Dis."},{"key":"ref-26","article-title":"Geographical expansion of cases of dengue and chikungunya beyond the historical areas of transmission in the Region of the Americas","year":"2023"},{"key":"ref-27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009624","article-title":"Changing epidemiology of dengue in Sri Lanka\u2014challenges for the future.","volume":"15","author":"G Malavige","year":"2021","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"2247-2255","DOI":"10.1093\/cid\/ciz499","article-title":"Dengue Infection complicated by Hemophagocytic Lymphohistiocytosis: experiences from 180 patients with Severe Dengue.","volume":"70","author":"F Kan","year":"2020","journal-title":"Clin Infect Dis."},{"key":"ref-29","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-1496-1","article-title":"C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study.","volume":"18","author":"N Vuong","year":"2020","journal-title":"BMC Med."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"745-59","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection.","volume":"15","author":"G Screaton","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"275-81","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial.","volume":"44","author":"B Shakoory","year":"2016","journal-title":"Crit Care Med."},{"key":"ref-32","article-title":"Appendix 1 for \u2018Anakinra for dengue patients with hyperinflammation protocol for a randomized double-blind placebo-controlled [Internet]","author":"H Tran","year":"2024"},{"key":"ref-33","article-title":"SPIRIT checklist for \u2018Anakinra for dengue patients with hyperinflammation protocol for a randomized double-blind placebo-controlled.","author":"H Tran","year":"2024","journal-title":"figshare."}],"container-title":["Wellcome Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:05:11Z","timestamp":1734570311000},"score":1,"resource":{"primary":{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":33,"URL":"https:\/\/doi.org\/10.12688\/wellcomeopenres.21017.1","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/wellcomeopenres.23252.r113221","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23252.r114078","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23252.r113224","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23252.r114078","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23252.r113221","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23252.r114083","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23252.r113224","asserted-by":"object"}]},"ISSN":["2398-502X"],"issn-type":[{"value":"2398-502X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"Indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/wellcomeopenres.23252.r114078, Arif Nur Muhammad Ansori, Universitas Airlangga, Surabaya, East Java, 04 Dec 2024, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1#referee-response-114078","order":0,"name":"referee-response-114078","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/wellcomeopenres.23252.r113224, Gathsaurie Neelika Malavige, University of Sri Jayewardenepura, Nugegoda, 16 Dec 2024, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1#referee-response-113224","order":1,"name":"referee-response-113224","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/wellcomeopenres.23252.r113221, Panisadee Avirutnan, Dumrong Mairiang, Division of Dengue Hemorrhagic Fever Research & Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Mahidol University, Bangkok, 19 Dec 2024, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-689\/v1#referee-response-113221","order":2,"name":"referee-response-113221","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by Wellcome [223004, <a href=https:\/\/doi.org\/10.35802\/223004>https:\/\/doi.org\/10.35802\/223004<\/a>]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}